Drug Trial Radar · NCT05303636
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Last checked: Nov 19, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,536
Actual
Start
Mar 28, 2022
Primary completion
Dec 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Insud PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Chemo Research
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 14 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD) at the lumbar spine after 12 months (13 medication cycles) of investigation in comparison to non-hormonal contraceptive methods. Secondary objectives include further evaluating the impact of LF111 and DRSP 3.5 mg chewable tablets on BMD and bone turnover after 12 months (13 medication cycles) in comparison to non-hormonal contraceptive methods and assessing the general safety and tolerability of LF111 and DRSP 3.5 mg chewable tablets in comparison to non-hormonal contraceptive methods. Exploratory objectives include evaluating the impact of LF111 and DRSP 3.5 mg chewable tablets on body fat and lean mass after 12 months (13 medication cycles) of investigation.
Conditions
- Change in Bone Mineral Density
- Bone Loss
Interventions
drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tabletDrug
Drospirenone 4 mg tablet (LF1111) orally daily on days 1-24, followed by placebo tablet orally daily on days 25-28 (available in USA and Europe) or drospirenone 3.5 mg chewable tablet chewed daily on days 1-24, followed by placebo tablet chewed daily on days 25-28) (available in USA only).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Mean absolute change in lumbar spine (L1-L4) Z-score in adolescentsTime frame: Baseline to 12 months
- Cohort 2: Mean percentage change in lumbar spine (L1-L4) BMD in adultsTime frame: Baseline to 12 months
Locations
37 sites in 3 countries. Site status is shown where the registry gives one.
Phoenix Childrens Hospital
Phoenix, Arizona
University of Colorado Denver - School of Medicine - Anschutz Medical Campus
Aurora, Colorado
Encore Medical Research of Boynton Beach LLC
Boynton Beach, Florida
Advanced Clinical Research Network
Coral Gables, Florida
BioMD Research
Coral Gables, Florida
Direct Helpers Research Center
Hialeah, Florida
Health Care Family Rehab & Research Center
Hialeah, Florida
Vital Pharma Research
Hialeah, Florida
Encore Medical Research, LLC
Hollywood, Florida
Cornerstone Research Institute
Longwood, Florida
D&H National Research Centers
Miami, Florida
Miami Clinical Research
Miami, Florida
Felicidad Medical Research, LLC
Miami, Florida
New Age Medical Research Corporation
Miami, Florida
KM International Research Operation LLC
Saint Cloud, Florida
Florida Pharmaceutical Research and Associates, Inc.
South Miami, Florida
Encore Medical Research of Weston LLC
Weston, Florida
Clinical Trials Management, LLC - Southshore
Metairie, Louisiana
University of Michigan C.S. Mott Children's Hospital
Ann Arbor, Michigan
Meridian Clinical Research
Norfolk, Nebraska
Lillestol Research LLC
Fargo, North Dakota
OB/GYN Associates of Erie
Erie, Pennsylvania
Signature Gyn Services
Fort Worth, Texas
TMC Life Research, Inc.
Houston, Texas
Tidewater Clinical Research, Inc.
Norfolk, Virginia
Children's Hospital of the King's Daughters
Norfolk, Virginia
Seattle Clinical Research Center
Seattle, Washington
Lékárna Devetsil JST s.r.o.
Slovany, Czechia
Lékárna U Zvonice
Vysoké Mýto, Czechia
Centrum Bocian Sp Z O. O. Spólka Komandytowa
Bialystok, Poland
Centrum Bocian Sp z o.o. Sp.
Katowice, Poland
GynCentrum Sp. z o.o.
Katowice, Poland
Vita Longa Sp. z o.o.
Katowice, Poland
Centrum Medyczne Linden
Krakow, Poland
Grazyna Bogutyn Medico Praktyka Lekarska
Krakow, Poland
CM Medyceusz, Apteka szpitalna
Lodz, Poland
Klinika Leczenia Nieplodnosci, Ginekologii i Poloznictwa Bocian
Warsaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.